Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis

Author:

Zhang Fei123,Wang Yun123,Wang Zhi-Qiang123,Sun Peng123,Wang De-Shen123,Jiang Yuan-Xue123,Zhang Dong-Sheng123,Wang Feng-Hua123,Xu Rui-Hua123,Li Yu-Hong123

Affiliation:

1. Collaborative Innovation Center for Cancer Medicine; Sun Yat-sen University Cancer Center; 651 Dongfeng East Road Guangzhou Guangdong 510060 China

2. State Key Laboratory of Oncology in South China; Sun Yat-sen University Cancer Center; 651 Dongfeng East Road Guangzhou Guangdong 510060 China

3. Department of Medical Oncology; Sun Yat-sen University Cancer Center; 651 Dongfeng East Road Guangzhou Guangdong 510060 China

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Reference23 articles.

1. Cancer Statistics;Siegel;CA Cancer J Clin,2014

2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

3. Cancer trends in China;Zhao;Jpn J Clin Oncol,2010

4. Esophageal cancer;Enzinger;N Engl J Med,2003

5. Esophageal carcinoma;Rustgi;N Engl J Med,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3